The latest news from Arcinova
Revving Up for the Revolution: Industry 4.0Revving Up for the Revolution: Industry 4.0 “The current change – from the third to the fourth industrial revolution – is marked by a move toward a consolidated, full-spectrum, data-driven a
Register now for Arcinova's webinar - Preformulation to first in human: avoiding pitfalls for early clinical successRegister now for Arcinova's webinar - Preformulation to first in human: avoiding pitfalls for early clinical success Preformulation characterization of new chemical entities (NCE) can be c
Paul Quigley joins advisory board of the Leeds’ EPSRC Centre for Doctoral Training in Molecules to ProductWe are thrilled to announce that our Head of Drug Substance, Paul Quigley, has been invited to join the advisory board of the Leeds’ EPSRC Centre for Doctoral Training in Molecules to Product.
Arcinova wins BVCA Yorkshire and North East business awards - Business Transformation Management TeamExciting news - we have won the Business Transformation Management Team title at the British Private Equity & Venture Capital Association (BVCA)’s Yorkshire and North East Management Team Aw
Arcinova’s Senior Director of Business Development Europe named 2020 Northern Powerhouse Export ChampionArcinova, a multi-service Contract Development and Manufacturing Organisation (CDMO) based in Northumberland, England, is delighted to announce that its Senior Director of Business Development Eur
Fantastic news - we are the highest-placed CDMO on Alantra's #PharmaFast50!Fantastic news - we are the highest-placed CDMO on Alantra's #PharmaFast50! We are delighted by this recognition of our work as a North East-based CDMO that serves the global Pharma indust
Arcinova Releases Latest Case Study - Capsule Product ManufacturingThe challenge - Accelerate first-in-human and Phase II trials for an oral dosage form intended for treatment of CNS disorders. A fully integrated approach was required, to include drug substance m
Arcinova Launches Latest VideoHave you ever wondered what our site looks like? View our video here
Arcinova Releases Latest Case Study - Precision FillingThe challenge - To rapidly manufacture a GMP-compliant API-in-capsule product for use in Phase I and Phase II clinical trials. The product was being investigated for treatments spanning mult
Discover how Arcinova can help
We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.